BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Intersect ENT 

(formerly Sinexus)
1049 Elwell Court
Palo Alto  California  94303  U.S.A.
Phone: 650-641-2100 Fax: n/a


SEARCH JOBS




Industry
Medical Device






 Company News
Intersect ENT Announces Positive Results From Pilot Study of Novel In-Office Implant for Chronic Sinusitis Patients 9/30/2013 10:59:17 AM    More...
Intersect ENT Announces Positive Results From Pilot Study of Novel in-Office Implant for Chronic Sinusitis Patients 9/30/2013 7:46:43 AM    More...
Intersect ENT Grabs $30 Million for Drug/Device Combo for the Sinuses 2/25/2013 7:51:18 AM    More...
Intersect ENT Initiates U.S. Clinical Study of a Novel In-Office Treatment for Chronic Sinusitis Patients 1/31/2013 10:17:01 AM    More...
Intersect ENT Announces FDA Approval of New Steroid-Releasing Implant 11/6/2012 6:56:22 AM    More...
Intersect ENT Release: Groundbreaking Clinical Evidence Demonstrates Benefit of PROPEL Implant for Chronic Sinusitis Patients 6/6/2012 12:26:53 PM    More...
Intersect ENT Quadruples Operation Size With Move to Menlo Park 4/18/2012 9:04:16 AM    More...
Intersect ENT Announces Positive Data from Pivotal Study of Propel Implant, Showing Significantly Improved Outcomes for Sinus Surgery 9/14/2011 6:50:15 AM    More...
Intersect ENT Announces U.S. FDA Approval for First Drug Releasing Implant for Chronic Sinusitis Patients 8/15/2011 6:34:45 AM    More...
Intersect ENT Closes $30M Series C Financing, Recognized for Clinical Science 11/1/2010 7:22:35 AM    More...
12